实用肝脏病杂志 ›› 2019, Vol. 22 ›› Issue (5): 624-635.doi: 10.3969/j.issn.1672-5069.2019.05.005
中华医学会肝病学分会, 中华医学会消化病学分会
收稿日期:2019-05-29
出版日期:2019-09-10
发布日期:2019-09-16
通讯作者:
段钟平,首都医科大学附属北京佑安医院 100069 E-mail：duan2517@163.com;杨云生，中国人民解放军总医院第一医学中心，100853 E-mail：sunny301ddc@126.com
Received:2019-05-29
Online:2019-09-10
Published:2019-09-16
Contact:
Duan Zhongping, Email: 中华医学会肝病学分会, 中华医学会消化病学分会. 终末期肝病临床营养指南[J]. 实用肝脏病杂志, 2019, 22(5): 624-635.
| [1] 贾继东. 终末期肝病的诊疗现状[J]. 中华肝脏病杂志,2007,15(6):401-402.DOI:10.3760/j.issn:1007-3418.2007.06.001. Jia JD. Diagnosis and treatment of end-stage liver disease[J]. CHINESE JOURNAL OF HEPATOLOGY,2007,15(6):401-402.DOI10.3760/j.issn:1007-3418.2007.06.001. [2] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J]. 中华肝脏病杂志,2019,27(1):18-26.DOI:10. 3760/cma.j.issn.1007-3418.2019.01.006. Liver Failure and Artificial Liver Group,Chinese Society of Infectious Diseases,Severe Liver Diseases and Artificial Liver Diseases,Chinese Society of Hepatology,Chinese Medical Association. Guideline for diagnosis and treatment of liver failure[J]. Chinese Journal of Hepatology,2019,27(1):18-26. DOI10.3760/cma.j.issn.1007-3418.2019.006. [3] Sarin SK,Kedarisetty CK,Abbas Z,et al.Acute-on-chronic liver failure:consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014[J]. Hepatology International,2014,8(4):453-471.DOI:10.1007/s12072-014-9580-2 [4] Cheung K,Lee SS,Raman M.Prevalence and mechanisms of malnutrition in patients with advanced liver disease,and nutrition management strategies[J]. Clin Gastroenterol Hepatol,2012,10(2):117-125.DOI:10.1016/j.cgh.2011.08.016 [5] Kalafateli M,Mantzoukis K,Choi Yau Y,et al.Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the Model for End-stage Liver Disease score[J]. J Cachexia Sarcopenia Muscle,2017,8(1):113-121.DOI:10.1002/jcsm.12095 [6] Plauth M,Merli M,Kondrup J,et al.ESPEN guidelines for nutrition in liver disease and transplantation[J]. Clin Nutr,1997,16(2):43-55. [7] Plauth M,Cabre E,Riggio O,et al. ESPEN Guidelines on Enteral Nutrition:Liver disease[J]. Clin Nutr,2006,25(2):285-DOI:10.OI:10.1016/j.clnu.2006.01.018 [8] Plauth M,Cabre E,Campillo B,et al.ESPEN Guidelines on Parenteral Nutrition:hepatology[J]. Clin Nutr,2009,28(4):436-444. DOI:10.1016/j.clnu.2009.04.019 [9] European Association For The Study Of The Liver. Electronic Address EEE,European Association For The Study Of The L. EASL Clinical Practice Guidelines on nutrition in chronic liver disease[J]. J Hepatol,2018.DOI:10.1016/j.jhep.2018.06.024 [10] 专家委员会北京医学会肠外肠内营养学专业委员会慢性肝病患者肠外肠内营养支持与膳食干预专家共识. 慢性肝病患者肠外肠内营养支持与膳食干预专家共识[J]. 中华临床营养杂志,2017,25(1):1-11.DOI:10.3760/cma.j.issn.1674-635X.2017.01. 001. Expert Panel on Consensus on the Clinical Nutritio. Consensus on the clinical nutritional intervention for patients with chronic liver diseases[J]. Chinese Journal of Clinical Nutrition,2017,25(1):1-11. DOI:10.3760/cma.j.issn.1674-635X.2017.01.001. [11] Tandon P,Raman M,Mourtzakis M,et al.A practical approach to nutritional screening and assessment in cirrhosis[J]. Hepatology,2017,65(3):1044-1057.DOI:10.1002/hep.29003 [12] Borhofen SM,Gerner C,Lehmann J,et al.The Royal Free Hospital-Nutritional Prioritizing Tool Is an Independent Predictor of Deterioration of Liver Function and Survival in Cirrhosis[J]. Dig Dis Sci,2016,61(6):1735-1743.DOI:10.1007/s10620-015-4015-z [13] Mcfarlane M,Hammond C,Roper T,et al.Comparing assessment tools for detecting undernutrition in patients with liver cirrhosis[J]. Clin Nutr ESPEN,2018,23:156-161.DOI:10. 1016/j.clnesp.2017.10.009 [14] 郭会敏,周莉,马文晨,等. 北京地区住院肝病患者营养风险的状况[J]. 中华肝脏病杂志,2013,21(10):734-738.DOI:10.3760/cma.j.issn.1007-3418.2013.10.004. Guo HM,L Zhou L,Ma WC,et al. Prevalence of nutritional risk among in-patients with liver diseases in Beijing,China[J]. Chinese Journal of Hepatology,2013,21(10):734-738. DOI:10.3760/cma.j.issn.1007-3418.2013.10.004. [15] 徐军辉,文习刚,罗金波,等. 术前营养支持对存在营养风险肝癌患者肝动脉化疗栓塞临床结局的影响[J]. 中华肝胆外科杂志,2018,24(4):226-230.DOI:10.3760/cma.j.issn. 1007-8118.2018. Chinese Journal of Hepatobiliary Surgery,2018,24(4):226-230. DOI:10.3760/cma.j.issn. 1007-8118.2018.04.003. [16] Mcclave SA,Taylor BE,Martindale RG,et al.Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)[J]. JPEN J Parenter Enteral Nutr,2016,40(2):159-211.DOI:10.1177/0148607115621863 [17] Tandon P,Ney M,Irwin I,et al.Severe muscle depletion in patients on the liver transplant wait list:Its prevalence and independent prognostic value[J]. Liver Transplantation,2012,18(10):1209-1216.DOI:10.1002/lt.23495 [18] 于红卫,侯维,时淑云,等. 不同营养评价方法在肝病病人中的比较及适宜肝病营养评价的方法[J]. 肠外与肠内营养,2016,23(2):82-86.DOI:10.16151/j.1007-810x.2016.02.005. Yu HW,Hou W,Shi SY,et al.Comparison of different nutritional assessments and a try of a new method in nutritional assessment for liver disease[J]. Parenteral & Enteral Nutrition,2016,23(2):82-86. DOI:10.16151/j.1007-810x.2016.02.005. [19] Lin H,Kim G,Kang SH,et al.Prognostic value of sarcopenia in patients with liver cirrhosis:A systematic review and meta-analysis[J]. Plos One,2017,12(10):e186990.DOI: 10.1371/journal. pone.0186990 [20] Carey EJ,Lai JC,Wang CW,et al.A multicenter study to define sarcopenia in patients with end-stage liver disease[J]. Liver Transpl,2017,23(5):625-633.DOI:10.1002/lt.24750 [21] Tandon P,Low G,Mourtzakis M,et al.A Model to Identify Sarcopenia in Patients With Cirrhosis[J].Clinical Gastroenterology and Hepatology,2016,14(10):1473-1480.DOI:10.1016/j. cgh. 2016.04.040 [22] Gu DH,Kim MY,Seo YS,et al.Clinical usefulness of psoas muscle thickness for the diagnosis of sarcopenia in patients with liver cirrhosis[J]. Clin Mol Hepatol,2018,24(3):319-330.DOI:10.3350/cmh.2017.0077 [23] Huguet A,Latournerie M,Debry PH,et al. The psoas muscle transversal diameter predicts mortality in patients with cirrhosis on a waiting list for liver transplantation:A retrospective cohort study[J]. Nutrition,2018,51-52:73-79.DOI:10.1016/j.nut.2018.008 [24] Sharma P,Rauf A,Matin A,et al.Handgrip Strength as an Important Bed Side Tool to Assess Malnutrition in Patient with Liver Disease[J]. J Clin Exp Hepatol,2017,7(1):16-22.DOI:10.1016/j.jceh.2016.10.005 [25] Wang CW,Feng S,Covinsky KE,et al.A Comparison of Muscle Function,Mass,and Quality in Liver Transplant Candidates:Results From the Functional Assessment in Liver Transplantation Study[J]. Transplantation,2016,100(8):1692-1698.DOI:10.1097/TP.0000000000001232 [26] 中华医学会骨质疏松和骨矿盐疾病分会. 肌少症共识[J]. 中华骨质疏松和骨矿盐疾病杂志,2016,9(3):215-227.DOI:10.3969/j.issn.1674-2591.2016.03.001. 27 Branch of Osteoporosis and Bone Mineral Salt Diseases,Chinese Medical Association. Consensus on oligomyosis[J]. Chinese Journal of Osteoporosis and Bone Mineral Research,2016,9(3):215-227. [27] Lai JC,Covinsky KE,Dodge JL,et al.Development of a novel frailty index to predict mortality in patients with end-stage liver disease[J]. Hepatology,2017,66(2):564-574.DOI:10.1002/hep.29219 [28] Cicho-Lach H,Michalak A.A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis[J]. Gastroenterology Research and Practice,2017,2017:1-10.DOI:10.1155/2017/6765856 [29] Belarmino G,Gonzalez MC,Torrinhas RS,et al.Phase angle obtained by bioelectrical impedance analysis independently predicts mortality in patients with cirrhosis[J]. World J Hepatol,2017,9(7):401-408.DOI:10.4254/wjh.v9.i7.401 [30] Kanis JA.Assessment of fracture risk and its application to screening for postmenopausal osteoporosis:synopsis of a WHO report. WHO Study Group[J]. Osteoporos Int,1994,4(6):368-381. [31] 郭长江,顾景范,杜寿玢. 《现代临床营养学》第二版[M]. 北京:科学出版社,2009:1-12. Gu JF,Du SF,Guo CJ. Modern Clinical Nutrition,2nd Edition [M]. Beijing:Science Press,2009:1-12. [32] Eslamparast T,Vandermeer B,Raman M,et al.Are Predictive Energy Expenditure Equations Accurate in Cirrhosis[J]. Nutrients,2019,11(2):334.DOI:10.3390/nu11020334 [33] Bounoure L,Gomes F,Stanga Z,et al.Detection and treatment of medical inpatients with or at-risk of malnutrition:Suggested procedures based on validated guidelines[J]. Nutrition,2016,32(7-8):790-798.DOI:10.1016/j.nut.2016.01.019 [34] Glass C,Hipskind P,Tsien C,et al.Sarcopenia and a physiologically low respiratory quotient in patients with cirrhosis:a prospective controlled study[J]. J Appl Physiol (1985),2013,114(5):559-565.DOI:10.1152/japplphysiol.01042.2012 [35] Detsky AS,Mclaughlin JR,Baker JP,et al.What is subjective global assessment of nutritional status[J]. JPEN J Parenter Enteral Nutr,1987,11(1):8-13.DOI:10.1177/014860718701100108 [36] Demirel B,Atasoy BM.Comparison of Three Nutritional Screening Tools to Predict Malnutrition Risk and Detect Distinctions Between Tools in Cancer Patients Receiving Radiochemotherapy[J]. Nutr Cancer,2018:1-7.DOI:10.1080/01635581.2018.1491606 [37] Marr KJ,Shaheen AA,Lam L,et al.Nutritional status and the performance of multiple bedside tools for nutrition assessment among patients waiting for liver transplantation:A Canadian experience[J]. Clin Nutr ESPEN,2017,17:68-74.DOI:10.1016/j.clnesp.2016.10.003 [38] Alvares-Da-Silva MR,Reverbel Da Silveira T. Comparison between handgrip strength,subjective global assessment,and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients[J]. Nutrition,2005,21(2):113-117.DOI:10.1016/j. nut.2004.02.002 [39] Figueiredo FA,Perez RM,Freitas MM,et al.Comparison of three methods of nutritional assessment in liver cirrhosis:subjective global assessment,traditional nutritional parameters,and body composition analysis[J]. J Gastroenterol,2006,41(5):476-482.DOI:10.1007/s00535-006-1794-1 [40] Morgan MY,Madden AM,Soulsby CT,et al.Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis[J]. Hepatology,2006,44(4):823-835. DOI:10.1002/hep.21358 [41] Ahluwalia N,Dwyer J,Terry A,et al.Update on NHANES Dietary Data:Focus on Collection,Release,Analytical Considera-tions,and Uses to Inform Public Polic[J]. Adv Nutr,2016,7(1): 121-134.DOI:10.3945/an.115.009258 [42] 于淑清,孟庆华,李玉贤,等. 慢性肝炎和肝炎后肝硬化患者能量代谢的研究[J]. 中华全科医师杂志,2007,6(10):607-610. Yu SQ,Meng QH,Li YX,et al.Study on energy metabolism in patients with chronic hepatitis and post-hepatitis cirrhosis[J].Chinese Journal of General Practitioners,2007,6(10):607-610. [43] 许静涌,杨剑,康维明,等. 营养风险及营养风险筛查工具营养风险筛查2002临床应用专家共识(2018版)[J]. 中华临床营养杂志,2018,26(3):131-135.DOI: 10.3760/cma.j.issn. 1674-635X. 2018.03.001. Xu JY,Yang J,Kang WM,et al.Nutritional Risk and Nutritional Risk Screening Tool Nutritional Risk Screening Expert Consensus 2002(2018 Edition)[J]. Chinese Journal of Clinical Nutrition,2018,26(3):131-135. [44] Eghtesad S,Poustchi H,Malekzadeh R.Malnutrition in liver cirrhosis:the influence of protein and sodium[J]. Middle East J Dig Dis,2013,5(2):65-75. [45] Guglielmi FW,Panella C,Buda A,et al.Nutritional state and energy balance in cirrhotic patients with or without hypermetabo-lism. Multicentre prospective study by the “Nutritional Problems in Gastroenterology” Section of the Italian Society of Gastroenterology(SIGE)[J]. Dig Liver Dis,2005,37(9):681-688.DOI:10.1016/j.dld.2005.03.010 [46] Nielsen K,Kondrup J,Martinsen L,et al.Nutritional assessment and adequacy of dietary intake in hospitalized patients with alcoholic liver cirrhosis[J]. British Journal of Nutrition,2007,69(03):665.DOI:10.1079/bjn19930068 [47] Johnson TM,Overgard EB,Cohen AE,et al.Nutrition assessment and management in advanced liver disease[J]. Nutr Clin Pract,2013,28(1):15-29.DOI:10.1177/0884533612469027 [48] Nardelli S,Lattanzi B,Torrisi S,et al.Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement[J]. Clin Gastroenterol Hepatol,2017,15(6):934-936.DOI:10.1016/j.cgh.2016.10.028 [49] Greenberger NJ,Carley J,Schenker S,et al.Effect of vegetable and animal protein diets in chronic hepatic encephalopathy[J]. Am J Dig Dis,1977,22(10):845-855. [50] Maharshi S,Sharma BC,Sachdeva S,et al.Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial[J]. Clin Gastroenterol Hepatol,2016,14(3):454-460,e33.DOI:10.1016/j.cgh.2015.028 [51] Plank LD,Gane EJ,Peng S,et al.Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis:A randomized 12-month trial[J]. Hepatology,2008,48(2):557-566.DOI:10.1002/hep.22367 [52] Everhart JE,Lok AS,Kim HY,et al.Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial[J]. Gastroenterology,2009,137(2):549-557.DOI:10.1053/j.gastro.2009.05.007 [53] Plauth M,Bernal W,Dasarathy S,et al.ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr,2019.DOI:S0261-5614(18)32590-1 [pii]10.1016/j.clnu.2018.12.022 [54] Gluud LL,Dam G,Les I,et al.Branched-chain amino acids for people with hepatic encephalopathy[J]. Cochrane Database Syst Rev,2017,5:D1939.DOI:10.1002/14651858. CD00 1939.pub4 [55] Jamil Z,Arif S,Khan A,et al.Vitamin D Deficiency and Its Relationship with Child-Pugh Class in Patients with Chronic Liver Disease[J]. J Clin Transl Hepatol,2018,6(2):135-140.DOI:10.14218/JCTH.2017.00055 [56] Colpo E,Gomes FJ,Gomes FI,et al.EFFECT OF ANTIOXIDANT POTENTIAL ON SEVERITY OF CIRRHOSIS IN HUMAN[J]. Nutr Hosp,2015,32(5):2294-2300.DOI:10. 3305/nh.2015.32.5.9641 [57] Shang N,Wang X,Shu Q,et al.The Functions of Selenium and Selenoproteins Relating to the Liver Diseases[J]. J Nanosci Nanotechnol,2019,19(4):1875-1888.DOI:10.1166/jnn.2019.16287 [58] Guerra TS,Hoehr NF,Boin IDFS,et al.Trace Elements in Plasma and Nutritional Assessment in Patients with Compensated Cirrhosis on a Liver Transplant List[J]. Arquivos de Gastroenterologia,2016,53(2):84-88.DOI:10.1590/s0004-28032016000200006 [59] Bresci G,Parisi G,Banti S.Management of hepatic encephalopathy with oral zinc supplementation:a long-term treatment[J]. Eur J Med,1993,2(7):414-416. [60] Takuma Y,Nouso K,Makino Y,et al.Clinical trial:oral zinc in hepatic encephalopathy[J]. Alimentary Pharmacology & Therapeutics,2010,32(9):1080-1090.DOI:10.1111/j. 1365-2036.2010. 04448.x [61] Iwasa M,I wata K,Hara N,et al. Nutrition therapy using a multidisciplinary team improves survival rates in patients with liver cirrhosis[J]. Nutrition,2013,29(11-12):1418-1421.DOI: 10.1016/j.nut.2013.05.016 [62] Guo Y,Tian Z,Jiang N,et al.Effects of Late Evening Snack on Cirrhotic Patients:A Systematic Review and Meta-Analysis[J]. Gastroenterology Research and Practice,2018,2018:1-10.DOI: 10.1155/2018/9189062 [63] Tsien CD,Mccullough AJ,Dasarathy S.Late evening snack: exploiting a period of anabolic opportunity in cirrhosis[J]. J Gastroenterol Hepatol,2012,27(3):430-441.DOI:10.1111/j.1440-1746.2011.06951. [64] Verboeket-Van DVW,Westerterp KR,van Hoek B,et al. Energy expenditure and substrate metabolism in patients with cirrhosis of the liver:effects of the pattern of food intake[J]. Gut,1995,36(1):110-116. [65] Gabe SM,Culkin A.Abnormal liver function tests in the parenteral nutrition fed patient[J]. Frontline Gastroenterology,2010,1(2):98-104.DOI:10.1136/fg.2009.000521 [66] Cavicchi M,Beau P,Crenn P,et al.Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure[J]. Ann Intern Med,2000,132(7):525-532.DOI:200004040-00003 [pii] [67] Navarro DA,Boaz M,Krause I,et al.Improved meal presentation increases food intake and decreases readmission rate in hospitalized patients[J]. Clin Nutr,2016,35(5):1153-1158.DOI: 10.1016/j.clnu.2015.09.012 [68] Yao J,Zhou X,Wang H,et al.Persistently Increased Resting Energy Expenditure Predicts Short-Term Mortality in Patients with Acute-on-Chronic Liver Failure[J]. Ann Nutr Metab,2018,73(1):2-9.DOI:10.1159/000487604 [69] Hou W,Li J,Lu J,et al.Effect of a carbohydrate-containing late-evening snack on energy metabolism and fasting substrate utilization in adults with acute-on-chronic liver failure due to Hepatitis B[J]. European Journal of Clinical Nutrition,2013,67(12):1251-1256.DOI:10.1038/ejcn.2013.163 [70] Gramlich L,Kichian K,Pinilla J,et al.Does enteral nutrition compared to parenteral nutrition result in better outcomes in critically ill adult patients A systematic review of the literature[J]. Nutrition,2004,20(10):843-848.DOI:10.1016/j.nut.2004.06.003 [71] Simpson F,Doig GS.Parenteral vs. enteral nutrition in the critically ill patient:a meta-analysis of trials using the intention to treat principle[J]. Intensive Care Med,2005,31(1):12-23.DOI: 10.1007/s00134-004-2511-2 [72] Harvey SE,Parrott F,Harrison DA,et al.Trial of the Route of Early Nutritional Support in Critically Ill Adults[J]. New England Journal of Medicine,2014,371(18):1673-1684.DOI: 10.1056/NEJMoa1409860 [73] De Jonghe B,Appere-De-Vechi C,Fournier M,et al. A prospective survey of nutritional support practices in intensive care unit patients:what is prescribed What is delivered[J]. Crit Care Med,2001,29(1):8-12. [74] Levine M,Stellpflug SJ,Pizon AF,et al.Hypoglycemia and lactic acidosis outperform King’s College criteria for predicting death or transplant in acetaminophen toxic patients[J]. Clinical Toxicology,2018,56(7):622-625.DOI:10.1080/15563650.2017.1420193 [75] Schütte K,Tippelt B,Schulz C,et al.Malnutrition is a prognostic factor in patients with hepatocellular carcinoma (HCC)[J]. Clinical Nutrition,2015,34(6):1122-1127.DOI:10.1016/j. clnu.2014.11.007 [76] Antonelli G,Gigante E,Iavarone M,et al.Sarcopenia is associated with reduced survival in patients with advanced hepatocellular carcinoma undergoing sorafenib treatment[J]. United European Gastroenterology Journal,2018,6(7):1039-1048.DOI:10.1177/2050640618781188 [77] Voron T,Tselikas L,Pietrasz D,et al.Sarcopenia Impacts on Short-and Long-term Results of Hepatectomy for Hepatocellular Carcinoma[J]. Ann Surg,2015,261(6):1173-1183.DOI:10.1097/ SLA. 0000000000000743 [78] Richter B,Schmandra TC,Golling M, et al.Nutritional Support after Open Liver Resection:A Systematic Review[J]. Digestive Surgery,2006,23(3):139-145.DOI:10.1159/000094345 [79] Chen L,Chen Y,Wang X,et al.Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma:a meta-analysis[J]. Nutr J,2015,14:67.DOI:10.1186/s12937-015-0056-6 [80] Morihara D,Iwata K,Hanano T,et al.Late-evening snack with branched-chain amino acids improves liver function after radiofrequency ablation for hepatocellular carcinoma[J]. Hepatology Research,2012,42(7):658-667.DOI:10.1111/j.1872-034X.2012.00969. [81] Nishikawa H,Osaki Y,Inuzuka T,et al.Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma[J]. World J Gastroenterol,2012,18(12): 1379-1384. DOI:10.3748/wjg.v18.i12.1379 [82] Nishikawa H,Enomoto H,Iwata Y,et al.Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis[J]. Medicine(Baltimore),2017,96(3):e5800. DOI:10.1097/MD.0000000000005800 [83] Hiraoka A,Hirooka M,Koizumi Y,et al.Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib[J]. Hepatology Research,2017,47(6):558-565.DOI:10.1111/hepr.12780 [84] Ellershaw J,Ward C.Care of the dying patient:the last hours or days of life[J]. BMJ,2003,326(7379):30-34. [85] Arends J,Bachmann P,Baracos V,et al.ESPEN guidelines on nutrition in cancer patients[J]. Clin Nutr,2017,36(1):11-48.DOI:10.1016/j.clnu.2016.07.015 [86] Morando F,Rosi S,Gola E,et al.Adherence to a moderate sodium restriction diet in outpatients with cirrhosis and ascites:a real-life cross-sectional study[J]. Liver International,2015,35(5): 1508-1515. DOI:10.1111/liv.12583 [87] 张宝刚,张克,张斌. 肝硬化食管胃静脉曲张行内镜下精准治疗的围手术期快速康复价值[J]. 中华消化内镜杂志,2018,35(6):432-433.DOI:10.3760/cma.j.issn.1007-5232.2018.06.013. Zhang BG,Zhang K,Zhang B.Chinese Journal of Digestive Endoscopy,Rapid perioperative rehabilitation value of precise endoscopic treatment for cirrhosis esophagogastric varices[J].Chinese Journal of Digestive Endoscopy,2018,35(6):432-433. DOI:10.3760/cma.j.issn. 1007-5232.2018.06.013. [88] 姜红梅,刘建光,杨靖. 内镜下治疗后早期口服营养液对肝硬化食管胃底静脉曲张破裂再出血的预防作用[J]. 实用肝脏病杂志,2016,19(4):490-491.DOI:10.3969/j.issn. 1672-5069.2016.04.030. Jiang HM,Liu JG,Yang J.Early oral administration of Ensure in patients with liver cirrhosis complicated by esophageal -gastric varices after endoscopic hemostasis[J]. Journal of Practical Hepatology,2016,19(4):490-491. DOI:10.3969/j.issn.1672-5069.2016.04.030. [89] Mendenhall CL,Anderson S,Weesner RE,et al.Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans Administration Cooperative Study Group on Alcoholic Hepatitis[J]. Am J Med,1984,76(2):211-222.DOI:0002-9343(84)90776-9 [pii] [90] Ferreira LG,Ferreira Martins AI,Cunha CE,et al.Negative energy balance secondary to inadequate dietary intake of patients on the waiting list for liver transplantation[J]. Nutrition,2013,29(10):1252-1258.DOI:10.1016/j.nut.2013.04.008 [91] Plank LD,Metzger DJ,Mccall JL,et al.Sequential changes in the metabolic response to orthotopic liver transplantation during the first year after surgery[J]. Ann Surg,2001,234(2):245-255. [92] Laryea M,Watt KD,Molinari M,et al.Metabolic syndrome in liver transplant recipients:Prevalence and association with major vascular events[J]. Liver Transplantation,2007,13(8):1109-1114.DOI:10.1002/lt.21126 |
| [1] | 王海舫, 杨大伟, 贾蓓, 张岁, 柳立平, 马文波, 解从君, 刘明书. 营养支持联合美他多辛治疗酒精性肝病患者肝功能和外周血细胞参数的变化[J]. 实用肝脏病杂志, 2019, 22(3): 381-384. |
| [2] | 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南（2018年版）[J]. 实用肝脏病杂志, 2019, 22(2): 164-171. |
| [3] | 王琦, 谢雯. 孕妇乙型肝炎病毒感染筛查与管理*[J]. 实用肝脏病杂志, 2019, 22(1): 9-12. |
| [4] | 宋娜, 刘晓燕, 刘畅, 山秀杰, 苏东峰, 李丽慧. 非酒精性脂肪性肝病合并2型糖尿病患者血浆促甲状腺激素水平变化及其临床意义*[J]. 实用肝脏病杂志, 2019, 22(1): 65-68. |
| [5] | 董雪莲, 张文均. 肝脏受控衰减参数检测早期无创发现代谢综合征人群价值分析*[J]. 实用肝脏病杂志, 2018, 21(6): 868-871. |
| [6] | 贾克丽, 韩际奥, 高晓. 血清前白蛋白和MELD评分对失代偿期乙型肝炎肝硬化患者预后的预测价值*[J]. 实用肝脏病杂志, 2018, 21(3): 348-351. |
| [7] | 李磊, 胡辉, 郑晓玮, 江守伟, 沈强. 四种基于MELD的评分系统对慢加急性乙型肝炎肝衰竭患者短期生存的预测价值分析*[J]. 实用肝脏病杂志, 2018, 21(3): 417-420. |
| [8] | 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 酒精性肝病防治指南（2018年更新版）[J]. 实用肝脏病杂志, 2018, 21(2): 170-176. |
| [9] | 中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南（2018年更新版）[J]. 实用肝脏病杂志, 2018, 21(2): 177-186. |
| [10] | 中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 实用肝脏病杂志, 2018, 21(1): 21-31. |
| [11] | 石翠翠，范建高. 美国非酒精性脂肪性肝病诊疗指南解读[J]. 实用肝脏病杂志, 2017, 20(5): 650-653. |
| [12] | 刘艳民，曾静，范建高. 2017亚太地区非酒精性脂肪性肝病指南简介[J]. 实用肝脏病杂志, 2017, 20(5): 654-655. |
| [13] | 曾静，范建高. 北美儿童非酒精性脂肪性肝病诊疗指南简介[J]. 实用肝脏病杂志, 2017, 20(5): 656-657. |
| [14] | 姚佳,原丽莉,段钟平. 肠道菌群对终末期肝病患者营养和代谢的作用[J]. 实用肝脏病杂志, 2017, 20(5): 513-515. |
| [15] | 吴江，范建高. 关注肝病患者肌少症[J]. 实用肝脏病杂志, 2017, 20(5): 516-519. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||
